Expert Explores Potential Role of Doublets and Triplets in IDH1-Mutant Acute Myeloid Leukemia
June 11th 2020Courtney D. DiNardo, MD, discusses the current treatment landscape for patients with IDH1-mutated acute myeloid leukemia and how potential doublet and triplet combinations may play a role in this setting.